FDA-approved epilepsy drug may help reverse osteoarthritis damage

3d-knee-joint-inflammation-osteoarthritis.webp

Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies.

Continue reading...

[ H/T ScienceDaily ]
  • Reading time 1 min read
  • Reading time 1 min read
  • Reading time 1 min read
  • Reading time 1 min read
  • Reading time 1 min read
  • Reading time 1 min read

Comments

There are no comments to display
Back
Top